Mesoblast (MESO) Inventory (2024 - 2025)
Mesoblast's (MESO) quarterly Inventory came in at $21.7 million in Q4 2025, down 10.46% year-on-year from $24.2 million in Q4 2024, and down 2.62% quarter-over-quarter from $22.2 million in Q2 2025.
Mesoblast (MESO) Inventory (2024 - 2025) Analysis & Trends
Mesoblast has disclosed Inventory across 2 years of filings, most recently posting $21.7 million for Q4 2025.
- Inventory for Q4 2025 came in at $21.7 million, down 10.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.7 million (down 10.46% YoY), and the FY2025 annual result was $22.2 million, changed N/A from the prior year.
- Inventory came in at $21.7 million for Q4 2025 at Mesoblast, down from $22.2 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $24.2 million in Q4 2024 to a low of $21.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 21.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.66 Mn |
| Jun 30, 2025 | 22.25 Mn |
| Dec 31, 2024 | 24.19 Mn |